Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

NCT00004862 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: oblimersen sodium
DRUG: cytarabine
DRUG: fludarabine phosphate

Sponsor

National Cancer Institute (NCI)